High mobility group box 1 (HMGB1) enhances porcine parthenotes developing in vitro in the absence of BSA

Theriogenology

Volumn 66, Issue 9, 2006, Pages 2077-2083

  Shen, Xing Hui ^a   Jin, Yong Xun ^a   Ko, Yeoung Gye ^b   Chung, Hak Jae ^b   Cui, Xiang Shun ^a   Kim, Nam Hyung ^a  

^a Chungbuk National University   (South Korea)

^b National Institute of Animal Science   (South Korea)

Author keywords

Apoptosis; HMGB1; In vitro culture; Parthenotes; Pig

Indexed keywords

BOVINE SERUM ALBUMIN; HIGH MOBILITY GROUP B1 PROTEIN;

ANIMAL; ANIMAL DISEASE; APOPTOSIS; ARTICLE; BLASTOCYST; CELL CULTURE; DOSE RESPONSE; DRUG EFFECT; EMBRYO CULTURE; EMBRYO DEVELOPMENT; METHODOLOGY; PARTHENOGENESIS; PRENATAL DEVELOPMENT; SWINE;

ANIMALS; APOPTOSIS; BLASTOCYST; CELLS, CULTURED; DOSE-RESPONSE RELATIONSHIP, DRUG; EMBRYO CULTURE TECHNIQUES; EMBRYONIC DEVELOPMENT; HMGB1 PROTEIN; PARTHENOGENESIS; SERUM ALBUMIN, BOVINE; SWINE;

SUIDAE; SUS SCROFA;

EID: 33846060228     PISSN: 0093691X     EISSN: None     Source Type: Journal    
DOI: 10.1016/j.theriogenology.2006.05.019     Document Type: Article

References (26)

1. Bustin M. Revised nomenclature for high mobility group (HMG) chromosomal proteins. Trends Biochem Sci 26 (2001) 152-153
2. Goodwin G.H., Sanders C., and Johns E.W. A new group of chromatin-associated proteins with a high content of acidic and basic amino acids. Eur J Biochem 38 (1973) 14-19
3. Bianchi M.E., and Beltrame M. Upwardly mobile proteins. Workshop: the role of HMG proteins in chromatin structure, gene expression and neoplasia. EMBO Rep 1 (2000) 109-114
4. Kwon J., Imbalzano A.N., Matthews A., and Oettinger M.A. Accessibility of nucleosomal DNA to V(D)J cleavage is modulated by RSS positioning and HMG1. Mol Cell 2 (1998) 829-839
5. Mitsouras K., Wong B., Arayata C., Johnson R.C., and Carey M. The DNA architectural protein HMGB1 displays two distinct modes of action that promote enhanceosome assembly. Mol Cell Biol 22 (2002) 4390-4401
6. Muller S., Scaffidi P., Degryse B., Bonaldi T., Ronfani L., Agresti A., et al. New EMBO members' review: the double life of HMGB1 chromatin protein: architectural factor and extracellular signal. EMBO J 20 (2001) 4337-4340
7. Taguchi A., Blood D.C., del Toro G., Canet A., Lee D.C., Qu W., et al. Blockade of RAGE-amphoterin signalling suppresses tumour growth and metastases. Nature 405 (2000) 354-360
8. Brezniceanu M.L., Volp K., Bosser S., Solbach C., Lichter P., Joos S., et al. HMGB1 inhibits cell death in yeast and mammalian cells and is abundantly expressed in human breast carcinoma. FASEB J 17 (2003) 1295-1297
9. Yang M.Y., and Rajamahendran R. Expression of Bcl-2 and Bax proteins in relation to quality of bovine oocytes and embryos produced in vitro. Anim Reprod Sci 70 (2002) 159-169
10. Nutt L.K., Gogvadze V., Uthaisang W., Mirnikjoo B., McConkey D.J., and Orrenius S. Indirect effects of Bax and Bak initiate the mitochondrial alterations that lead to cytochrome c release during arsenic trioxideinduced apoptosis. Cancer Biol Ther 4 (2005) 459-467
11. Kure-bayashi S., Miyake M., Katayama M., Miyano T., and Kato S. Development of porcine blastocyst from in vitro-maturated and activated haploid and diploid oocytes. Theriogenology 46 (1996) 1027-1036
12. Thuan N.V., Harayama H., and Miyake M. The development of porcine parthenogenetic diploid oocytes with homogeneous genomic components in vitro. J Reprod Dev 48 (2002) 157-166
13. Cui X.S., and Kim N.H. Epidermal growth factor induces Bcl-xL gene expression and reduces apoptosis in porcine parthenotes developing in vitro. Mol Reprod Dev 66 (2003) 273-278
14. Lee J.W., Tian X.C., and Yang X. Optimization of parthenogenetic activation protocol in porcine. Mol Reprod Dev 68 (2004) 51-57
15. Livak K.J., and Schmittgen T.D. Analysis of relative gene expression data using real-time quantitative PCR and the 2(Delta Delta C (T)) Method. Methods 25 (2001) 402-408
16. SAS user's guide (1985), Statistical Analysis System, Inc., Cary, NC, USA
17. Steel R.G.D., and Torrie J.H. Principles and procedures of statistics (1980), McGraw Hill Book Co., NY
18. Pasqualini J.R., Sterner R., Mercat P., and Allfrey V.G. Estradiol enhanced acetylation of nuclear high mobility group proteins of the uterus of newborn guinea pigs. Biochem Biophys Res Commun 161 (1989) 1260-1266
19. Prendergast P., Onate S.A., Christensen K., and Edwards D.P. Nuclear accessory factors enhance the binding of progesterone receptor to specific target DNA. J Steroid Biochem Mol Biol 48 (1994) 1-13
20. Zhang C.C., Krieg S., and Shapiro D.J. HMG-1 stimulates estrogen response element binding by estrogen receptor from stably transfected HeLa cells. Mol Endocrinol 13 (1999) 632-643
21. Cui X.S., Jeong Y.J., Jun J.H., and Kim N.H. Insulin-like growth factor-I alters apoptosis related genes and reduces apoptosis in porcine parthenotes developing in vitro. Theriogenology 63 (2005) 1070-1080
22. Bianchi M.E., Beltrame M., and Paonessa G. Specific recognition of cruciform DNA by nuclear protein HMG1. Science 243 (1989) 1056-1059
23. Boise L.H., Gonzales-Garcia M., Postema C.E., Ding L.A., Lindsten T., Turka L., et al. Bcl-x, a bcl-2 related gene that functions as a dominant regulator of apoptotic cell death. Cell 74 (1993) 597-608
24. Jayaraman L., Moorthy N.C., Murthy K.G., Manley J.L., Bustin M., and Prives C. High mobility group protein-1 (HMG-1) is a unique activator of p53. Genes Dev 12 (1998) 462-472
25. Romine L.E., Wood J.R., Lamia L.A., Prendergast P., Edwards D.P., and Nardulli A.M. The high mobility group protein 1 enhances binding of the estrogen receptor DNA binding domain to the estrogen response element. Mol Endocrinol 12 (1998) 664-674
26. Stros M., Ozaki T., Bacikova A., Kageyama H., and Nakagawara A. HMGB1 and HMGB2 cell-specifically down-regulate the p53- and p73-dependent sequence-specific transactivation from the human Bax gene promoter. J Biol Chem 277 (2002) 7157-7164